共 50 条
Classification of pulmonary alveolar proteinosis in newborns, infants, and children
被引:0
|作者:
Brasch, F
[1
]
Müller, KM
[1
]
机构:
[1] Ruhr Univ Bochum, Berufsgenossenschaftliche Kliniken Bergmannsheil, Inst Pathol, D-44789 Bochum, Germany
来源:
PATHOLOGE
|
2004年
/
25卷
/
04期
关键词:
pulmonary alveolar proteinosis;
surfactant;
SFTPB-mutations;
SFTPC-mutations;
congenital surfactant defects;
D O I:
10.1007/s00292-004-0706-5
中图分类号:
R36 [病理学];
学科分类号:
100104 ;
摘要:
Pulmonary alveolar proteinoses are rare pulmonary diseases characterised by an intraalveolar accumulation of surfactant protein A. Subtyping of alveolar proteinoses: Type I alveolar proteinoses: severe respiratory insufficiency in newborns, which will take a lethal course without lung transplant; hereditary SP-B deficiency and an intraalveolar accumulation of N-terminal incompletely processed SP-C. Type II alveolar proteinoses: occur in newborns and infants; often take a lethal course; show intraalveolar accumulation of precursors of SP-B and mature SP-B as well as an accompanying interstitial lung disease of variable severity. Type III alveolar proteinoses: in infants and children; do not generally take a lethal course; they are characterised by an intraalveolar accumulation of precursors of SP-B and mature SP-B without accompanying interstitial lung disease. "Cryptogenic" congenital, acquired (idiopathic), and secondary type III alveolar proteinoses can be distinguished. In newborns, infants, and children with pulmonary alveolar proteinosis, a detailed pathological-anatomical examination including immunohistochemical and molecular genetic analyses, should be performed in order to optimise the therapeutical management.
引用
收藏
页码:299 / 309
页数:11
相关论文